论文部分内容阅读
目的探讨瑞格列奈治疗2型糖尿病的疗效。方法对136例2型糖尿病患者服用瑞格列奈0.5~4 mg,3次/d,用药12周观察疗效。结果治疗前空腹血糖(9.02±1.33)mmol/L,治疗后空腹血糖(6.30±1.13)mmol/L,治疗前餐后2 h血糖(15.89±2.32)mmol/L,治疗后餐后2 h血糖(10.23±1.05)mmol/L。结论瑞格列奈治疗2型糖尿病疗效确切,且能重塑人体胰岛素分泌的生理模式。
Objective To investigate the curative effect of repaglinide on type 2 diabetes mellitus. Methods 136 patients with type 2 diabetes were treated with repaglinide 0.5 ~ 4 mg three times a day for 12 weeks. Results Before treatment, fasting blood glucose (9.02 ± 1.33) mmol / L, fasting blood glucose (6.30 ± 1.13) mmol / L and blood glucose (2) before and after treatment were (15.89 ± 2.32) mmol / (10.23 ± 1.05) mmol / L. Conclusion Repaglinide is effective in treating type 2 diabetes mellitus and can reshape the physiological pattern of human insulin secretion.